Related Experiment Video
Updated: Jun 13, 2025
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Effectiveness of lifestyle-modification approach (a randomized-controlled program of diet restriction and treadmill
Ali Mohamed Ali Ismail1, Ahmed Mahmoud Nasr Tolba2
1Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Giza, Egypt. ali.mohamed@pt.cu.edu.eg.
Introduction:
Chronic subjective tinnitus complaint (CSTC) is highly prevalent in metabolic syndrome (MS) elderly. In 60 obese MS elderly with CSTC, studying the response of CSTC-related discomfort, MS components, and CSTC severity to lifestyle-modification approach was the aim of this study.
Methods:
In this randomized/controlled lifestyle-modification trial, the recruitment of 60 obese MS elderly with CSTC from a local general hospital was randomly executed. The recruited elderly with MS and CSTC were randomly assigned to a study group (performed lifestyle-modification approach and the components of this 12-week approach were on-electrical treadmill walking plus diet restriction) or waitlist/control group (n = 30). Besides MS components/variables such as elderly's waist circumference (WC), elderly's fasting glucose in serum (FGIS), elderly's triglycerides (TriGly), elderly's blood pressure, and elderly's high-density lipoprotein (HDLipo), lifestyle-modification approach's outcomes of this trial were elderly's body mass index, visual analogue scale (VAS) of CSTC-related discomfort, tinnitus handicap inventory (THI), and VAS of CSTC severity.
Results:
Tracking all outcomes of this lifestyle-modification approach in the study group (n = 30 MS elderly with CSTC) showed significant improvements while the control group's outcome did not improve.
Conclusion:
BMI, VAS of CSTC severity, components of MS (WC, FGIS, blood pressure, TriGly, and HDLipo), THI, and VAS of CSTC-related discomfort could be improved after involving obese MS elderly with CSTS in a 12-week lifestyle-modification approach.
Trial Registration Number:
NCT06702085.
